Tetracycline-Regulated Gene Expression in Transgenic Mouse Epidermis

  • Rose-Anne Romano
  • Satrajit Sinha
Part of the Methods in Molecular Biology book series (MIMB, volume 585)


The ability to specifically manipulate gene expression in vivo using mouse models has been one of the most important advances in understanding gene function over the last few decades. Methods used to control gene activities in the mouse include gene targeting and transgenic approaches. While gene targeting methods have proven to be powerful genetic tools designed to eliminate gene function by creating a “knockout” or “null mutant,” transgenic studies offer gain-of-function capabilities, expression of dominant negative or knockdown of specific target genes and thus have often served a complementary and useful role. This chapter provides an overview for the generation of transgenic mouse models to study important questions in skin biology by taking advantage of the tetracycline-inducible gene expression system.

Key words

Keratinocyte Transgenic Tet-Effector Tet-Responder Skin Inducible 



Work in our laboratory is supported by National Institutes of Health Grant R01GM069417 and RO1AR049238 (S.S.).


  1. 1.
    Gossen, M. and H. Bujard. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89(12): pp. 5547–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Gossen, M., et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268(5218): pp. 1766–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Gossen, M. and H. Bujard. (2002) Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 36: pp. 153–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Tumbar, T., et al. (2004) Defining the epithelial stem cell niche in skin. Science 303(5656): pp. 359–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Diamond, I., et al. (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 115(5): pp. 788–94.PubMedCrossRefGoogle Scholar
  6. 6.
    Vitale-Cross, L., et al. (2004) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 64(24): pp. 8804–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Guo, Y., et al. (1999) Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression. Mol Carcinog 26(1): pp. 32–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Xie, W., et al. (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 18(24): pp. 3593–607.PubMedCrossRefGoogle Scholar
  9. 9.
    Dunbar, M.E., et al. (2001) Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. J Endocrinol 171(3): pp. 403–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Nguyen, H., M. Rendl, and E. Fuchs. (2006) Tcf3 governs stem cell features and represses cell fate determination in skin. Cell 127(1): pp. 171–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Ye, L., et al. (2001) Regulated expression of the human CFTR gene in epithelial cells. Mol Ther 3(5 Pt 1): pp. 723–33.PubMedCrossRefGoogle Scholar
  12. 12.
    Jaubert, J., et al. (2004) Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epidermal conditional gene expression. J Invest Dermatol 123(2): pp. 313–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Brinster, R.L., et al. (1985) Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82(13): pp. 4438–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Nagarajan, P., and S. Sinha. (2008) Development of an inducible gene expression system for primary murine keratinocytes. J Dermatol Sci 49(1): pp. 73–84.PubMedCrossRefGoogle Scholar
  15. 15.
    Kistner, A., et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93(20): pp. 10933–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Urlinger, S., et al. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97(14): pp. 7963–8.PubMedCrossRefGoogle Scholar
  17. 17. Romano, R., et al. (2009). An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 2009 May 20; 4(5): e5623.Google Scholar
  18. 18.
    Taketo, M., et al. (1991) FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88(6): pp. 2065–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Tymms, J., and Kola, I. (2001) Gene Knockout Protocols. Humana Press, Totowa, New Jersey.CrossRefGoogle Scholar
  20. 20.
    Cawthorne, C., et al. (2007) Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model. J Biomol Tech 18(2): pp. 120–3.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Rose-Anne Romano
    • 1
  • Satrajit Sinha
    • 2
  1. 1.Department of BiochemistryState University of New York at BuffaloBuffaloUSA
  2. 2.Department of Biochemistry, Center of Excellence in Bioinformatics and Life SciencesState University of New York at BuffaloBuffaloUSA

Personalised recommendations